NeoChord, Inc.

medical devices

About

NeoChord, Inc. is a medical technology company based in Minnesota, founded in 2007. The company specializes in beating heart mitral valve repair for patients with mitral valve regurgitation, focusing on minimally invasive procedures that eliminate the need for open-heart surgery. The flagship product, the NeoChord Artificial Chordae Delivery System (Model DS1000), allows for the implantation of artificial chordae tendineae on a beating heart using echocardiographic guidance. This innovative approach aims to restore normal valve function and has been adopted in various healthcare settings, including Queen Mary Hospital in Hong Kong. NeoChord also offers platforms like NeoChord ConsultConnect and ConnectCARD to support healthcare providers in the treatment process. With over 1,700 patients treated globally, NeoChord continues to expand its offerings, including the NeoChord NeXus, a transcatheter chordal repair system, reinforcing its commitment to improving patient outcomes in mitral valve treatment.

Technologies

SendgridOutlookMicrosoft Office 365VimeoMobile FriendlyNginxWoo CommerceWordPress.orgGoogle Tag ManagerRemote

Keywords

cardiac surgerycardiologyinterventional cardiologyphysicianmedical devicemitral valve repairfellowsclinical researchmedical equipment manufacturingmitral valve re-repairmedical equipment and supplies manufacturingclinical trialstranscatheter mitral repairservicestranscatheter mitral valve repairechocardiography-guided interventionregenerative mitral valve repairce marked medical devicemedical consultation servicesminimally invasive cardiac procedurecardiovascular devicestranscatheter transseptal systemmitral valve regurgitationmitral valve disease treatmentb2btransapical off-pump proceduremedical devicesconnectcardbeating heart mitral valve repairartificial chordae delivery system

Location

10900 73rd Ave N, Maple Grove, Minnesota, United States, 55369-2680

Related Companies

Companies in the same industry